Latest Articles
Mesothelin as a Diagnostic Biomarker in Endometriosis: A Cross-Sectional Study.
Endometriosis is a prevalent gynecological condition often requiring invasive procedures for diagnosis. This study aimed to assess mesothelin (MSLN) as a potential non-invasive biomarker by analyzing its levels in peritoneal …
Published: Nov. 28, 2025, midnight
Endometrial Stromal Cells from Endometriosis Patients Reflect Lesion-Type-Specific Heterogeneity.
Endometriosis, a disease affecting about one out of ten women, is characterized by the growth of endometrial-like tissue outside the uterine cavity. There is significant disease heterogeneity, but the pathophysiological …
Published: Nov. 28, 2025, midnight
Researchers issue warning after discovering overlooked threat to reproductive health: 'More significant effects' - Yahoo
Researchers issue warning after discovering overlooked threat to reproductive health: 'More significant effects' Yahoo
Published: Nov. 27, 2025, 11 p.m.
Elite Women’s Health: Why Endometriosis Must Be a Priority - Medical Tourism Magazine
Elite Women’s Health: Why Endometriosis Must Be a Priority Medical Tourism Magazine
Published: Nov. 27, 2025, 6:12 p.m.
Integrating inflammatory biomarkers and demographic variables with machine learning to predict endometriosis risk - Nature
Integrating inflammatory biomarkers and demographic variables with machine learning to predict endometriosis risk Nature
Published: Nov. 27, 2025, 5:43 p.m.
Research Challenges Menstrual Taboo, Promotes Inclusion - Mirage News
Research Challenges Menstrual Taboo, Promotes Inclusion Mirage News
Published: Nov. 27, 2025, 12:18 p.m.
Amazon has matched Best Buy's stunning AirPods offer — get AirPods 4 for their lowest-ever price - Mashable
Amazon has matched Best Buy's stunning AirPods offer — get AirPods 4 for their lowest-ever price Mashable
Published: Nov. 27, 2025, 11:55 a.m.
Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells - News-Medical
Exploring the combined antiproliferative effects of artesunate and resveratrol in Ishikawa endometrial cancer cells News-Medical
Published: Nov. 27, 2025, 10:29 a.m.
Endometriosis Treatment Market at $1.55B, 7.7% CAGR - openPR.com
Endometriosis Treatment Market at $1.55B, 7.7% CAGR openPR.com
Published: Nov. 27, 2025, 10:19 a.m.
Endometriosis Market Analysis and Sales Forecast to 2034 - Leveraging Robust Pipeline Products, Tapping Into Emerging Markets, and Forming Strategic Partnerships - Yahoo Finance
Endometriosis Market Analysis and Sales Forecast to 2034 - Leveraging Robust Pipeline Products, Tapping Into Emerging Markets, and Forming Strategic Partnerships Yahoo Finance
Published: Nov. 27, 2025, 9:15 a.m.
Link copied to clipboard!